Succinate dehydrogenase–deficient gastrointestinal stromal tumor of the stomach: EUS and contrast-enhanced EUS features (with videos)
Alberto Martino(Ospedale Antonio Cardarelli), Giovanni Lombardi(University of Rome Tor Vergata), Giuseppina Dell’Aversano Orabona(Ospedale Antonio Cardarelli), Enrico Crolla(Ospedale Antonio Cardarelli), Carlo Molino(Fatebenefratelli Hospital), Severo Campione(Federico II University Hospital), Lorenzo Anastasio(Ospedale Antonio Cardarelli), Marco Di Serafino(Ospedale Antonio Cardarelli), Roberto Fiorentino(Ospedale Antonio Cardarelli), Ferdinando Riccardi(Ospedale Antonio Cardarelli), Annalisa de Leone(Ospedale Antonio Cardarelli), Salvatore Picascia(Ospedale Antonio Cardarelli)
Cited by 0
Related Papers
First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The TORCH Randomized Trial
|Journal of Clinical Oncology|2012|234
Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial
|Journal of Clinical Oncology|2017|186
Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study
|The Journal of Clinical Endocrinology & Metabolism|2019|180
Real-World Study of Everolimus in Advanced Progressive Neuroendocrine Tumors
|The Oncologist|2014|103
Increase in the Content of Quinolinic Acid in Cerebrospinal Fluid and Frontal Cortex of Patients with Hepatic Failure
|Journal of Neurochemistry|1986|92